Overexpression of B cell-activating factor (BAFF) in neutrophils of oral cavity cancer patients - Preliminary study

Neoplasma

Volumn 58, Issue 3, 2011, Pages 211-216

  Jablonska, E ^a   Slodczyk, B ^b   Wawrusiewicz Kurylonek, N ^a   Garley, M ^a   Dziemianczyk, D ^a   Kretowski, A ^a   Grabowska, S Z ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b Diagnostic Laboratory CD Slodczyk Ltd   (Poland)

Author keywords

BAFF; Oral cavity cancer; PBMCs; PMNs

Indexed keywords

B CELL ACTIVATING FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TNFSF13B PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; LEUKOCYTE; MOUTH CANCER; NEUTROPHIL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; SQUAMOUS CELL CARCINOMA; BLOOD; CHEMISTRY; GENETICS; IMMUNOLOGY; MIDDLE AGED; MOUTH TUMOR; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; B-CELL ACTIVATING FACTOR; BLOTTING, WESTERN; HUMANS; MIDDLE AGED; MOUTH NEOPLASMS; NEUTROPHILS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 79961104487     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2011_03_211     Document Type: Article

References (30)

1. LIN WN, KARIN M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007; 117: 1175-1183. doi:10.1172/JCI31537
2. MANTOVANI A, ALLAVENA P, SICA A. Cancer-related inflammation. Nature 2008; 454: 436-44. doi:10.1038/nature07205
3. CASSATELLA MA. On the production of TNF-related apoptosis-inducing ligand (TRAIL/APO-2L) by human neutrophils. J Leukocyte Biol 2006; 79: 1140-1149. doi:10.1189/jlb.1005558
4. DI CARLO E, FORNI G, LOLLINI PL, COLOMBO MP, MODESTI A et al. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001; 97: 339-345. doi:10.1182/blood.V97.2.339
5. SCAPINI P, BAZZONI F, CASSATELLA MA. Regulation of B-cell-activating factor (BAFF)/Blymphocyte stimulator (BLyS) expression in human neutrophils. Immunol Lett 2008; 116: 1-6.
6. Mhawech-Fauceglia P, KAYA G, SAUTER G, MCKEE T, DONZE O et al. The source of APRIL up-regulation in human solid lesions. J Leukocyte Biol 2006; 80: 697-704. doi:10.1189/jlb.1105655
7. KOGA Y, MATSUZAKI A, SUMINOE A, HATTORI H, HARA T. Neutrophil-derived TNF-related apoptosis-inducing ligand (TRAIL): a novel mechanism of antitumor effect by neutrophils. Cancer Res 2004; 64: 1037-1043. doi:10.1158/0008-5472.CAN-03-1808
8. JABLONSKA E, JABLONSKI J, MARCINCZYK M, GRABOWSKA Z, PIOTROWSKI L et al. The release of solu- ble form sof TRAIL and DR5 by neutrophils of oral cavity cancer patients. Folia Histochem Cytobiol 2008; 46: 177-183. doi:10.2478/v10042-008-0027-2
9. JABLONSKA E, KILUK M, PIOTROWSKI L, GRABOWSKA Z, MARKIEWICZ W et al. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors In the culture super- natants of polymorphonuclear cells from cancer patients. Eur Cytokine Netw 1998; 9: 155-159.
10. NAGARAJ NS, VIGNESWARAN N, ZACHARIAS W. Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells. J Cancer Res Clin Oncol 2006; 132: 171-183. doi:10.1007/ s00432-005-0053-9
11. TENG MS, BRADWEIN-GENSLER MS, TEIXEIRA MS, MARTIGNETTI JA, DUFFEY DC. A study of TRAIL recep- tors in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 2005; 131: 407-412.
12. MACKAY F, TANGYE SG. The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. Curr Opin Phar- macol 2004; 4: 347-354. doi:10.1016/j.coph.2004.02.009
13. NG LG, MACKAY CR, MACKAY F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 2005; 42: 763-772. doi:10.1016/j.molimm.2004.06.041
14. SCAPINI P, CARLETTO A, NARDELLI B, CALZETTI F, ROSCHKE V et al. Proinflammatory mediators elicit secretion of the intracellular B-lymphocyte stimulator pool (BLyS) that is stored in activated neutrophils: implications for inflammatory diseases. Blood 2005; 105: 830-837. doi:10.1182/blood-2004-02-0564
15. HASE H, KANNO Y, KOJIMA M, HASEGAWA K, SAKURAI D et al. BAFF/BlyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood 2004; 103: 2257-2265. doi:10.1182/blood-2003-08-2694
16. LITYNSKIY M, Nardelli B, HILBERT BM, HE B, SCHAFFER A et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002; 3: 822-829. doi:10.1038/ni829
17. SUTHERLAND APR, NG LG, FLETCHER CA et al. BAFF augments certain Th1-associated inflammatory responses. J Immunol 2005; 174: 5537-5544.
18. Pelekanou V, Kampa M, Kafousi M, Darivianaki K, Sanidas E et al. Expression of TNF-superfamily members BAFF and APRIL in breast cancer: Immunohistochemical study in 52 invasive ductal breast carcinomas. BMC Cancer 2008; 8: 76-84. doi:10.1186/1471-2407-8-76
19. HAO Y, TRIADAFILOPOULOS G, SAHBAIE P et al. Gene ex- pression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma. Gastroenter- ology 2006; 131: 925-933. doi:10.1053/j.gastro.2006.04.026
20. CLOUTIER A, EAR T, BLAIS-CHARRON E, DUBOIS CM, MCDONALD PP. Differential involvement of NF-kappaB and MAP kinase pathways in the generation of inflammatory cytokines by human neutrophils. J Leukoc Biol 2007; 81: 567-577. doi:10.1189/jlb.0806536
21. BUONOCORE S, HADDOU NO, MOORE F, FLORQUIN S, PAULART F. YAMASHITA T, BANDO T et al. Neutrophil- dependent tumor rejection and priming of tumoricidal CD8+T cell response induced by dendritic cells overexpressiong CD95L. J Leukoc Biol 2008; 84: 713-720. doi:10.1189/jlb.0108075
22. MCKEOWN STW, LUNDY FT, NELSON J, LOCHART D, IRWIN CR et al. The cytotoxic effects of human neutrophils peptide-1 (HNP1) and lactoferrin on oral squamous cell carcinoma (OSCC) in vitro. Oral Oncol 2006; 42: 685-690. doi:10.1016/j.oraloncology.2005.11.005
23. WU QD, WANG JH, CONDRON C, Bouchier-Chayes D, REDMOND P et al. Human neutrophils facilitate tumor cell transendothelial migration. Am J Physiol Cell Physiol 2001; 280: C814-C822.
24. LATHERS DMR, YOUNG MRI. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine 2004; 25: 220-228. doi:10.1016/j.cyto.2003.11.005
25. SUGIMOTO C, FUIJEDA S, SUNAGA H. Granulocyte colony-stimulating factor (G-CSF)-mediated signaling regulates type IV collagenase activity in head and neck cancer cells. Int J Cancer 2001; 93: 42-46. doi:10.1002/ijc.1297
26. TAMATAMI T, AZUMA M, AOTA K et al. Enhanced IkappaB kinase activity of NF-kappaB in human head and neck carcinoma cells. Cancer Lett 2001; 171: 165-172. doi:10.1016/ S0304-3835(01)00611-5
27. PRASAD S, RAVINDRAN J, AGGARWAL BB. NF-kB and cancer: how intimate is this relationship. Mol Cell Biochem 2010; 336: 25-37. doi:10.1007/s11010-009-0267-2
28. MOREAUX J, LEGOUFFE E, JOURDAN E, QUITTET P, REME T et al. BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone. Blood 2004; 103: 3148-3157. doi:10.1182/blood-2003-06-1984
29. TORUNER GA, ULGER C, ALKAN M, GALANTE AT, RINAGGIO J et al. Association between gene expression profile and tumor invasion in oral squamous cell carci- noma. Cancer genetics and cytogenetics 2004; 154: 27-35. doi:10.1016/j.cancergencyto.2004.01.026
30. YOUNES A, KADIN ME. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy. J Clin Oncol 2003; 21: 3526-3534. doi:10.1200/ JCO.2003.09.037